This is a seasonal limited production run. Available to pre-order now through July, 2010. Product will ship mid-end of July.
Download info flier
Eniva Chromium (symbol "Cr") is supplied as trivalent chromium. Most chromium in foods occurs in this trivalent form. Highly refined foods may have diminished chromium levels.*
Minerals for Life® Chromium is a liquid dietary supplement of the mineral Chromium in a proprietary advanced aqueous nutrient delivery system. The purer the water the more efficiently minerals are activated into their electrically charged ionic state. Eniva uses OHM® water (multi-step purified water) in a unique proprietary process at Eniva's government-inspected manufacturing facility, yielding a bio-available form of chromium ions (Solutomic®) in sparkling clear solution for quicker absorption than tablets or capsules which must first dissolve in the digestive system before being absorbed.
Chromium is essential to the metabolism of lipids, glucose, and insulin. Because of its role in these processes, chromium helps the body maintain healthy energy levels and normal mental alertness.*
Chromium Helps to Support:
|Serving Size: 1 Teaspoon |
Servings Per Container: 120
Amount Per Serving
% Daily Value
Ingredients: Purified water, chromium (from chromium chloride).
Adult Directions: Take 1 teaspoon daily with meal.
No Stimulants, No Artificial Colors, No Artificial Flavors
Caution: Do not consume if tamper resistant seal is broken or missing. Keep cap tightly closed and out of reach of children. Not intended for children under 14 years of age. Not for pregnant or lactating women. First consult your physician before starting this or any new mineral or nutrient supplement program. Isolated minerals or nutrients are best taken as part of a comprehensive supplement program containing a broad spectrum of nutrients.
Abraham AS, Brooks BA, and Eylath U. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin dependent diabetes. Metabolism. 41: 768-771, 1992.
Anderson RA. Chromium in the prevention and control of diabetes. Diabetes & Metabolism. 26(1):22-7, 2000.
Anderson RA. Cheng N. Bryden NA. Polansky MM. Cheng N. Chi J. Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 46(11):1786-91, 1997.
Anderson RA. Chromium, glucose tolerance, and diabetes. Biological Trace Element Research. 32: 19-24, 1992.
Canfield W. Chromium, glucose tolerance and serum cholesterol in adults. In: Shapcott D and Hubert J (eds), Chromium in Nutrition and Metabolism. Amsterdam: Elsevier, 1979.
Clausen J. Chromium induced clinical improvement in symptomatic hypoglycemia. Biological Trace Element Research. 17:229-36, 1988.
Elias AN, Grossman MK and Valenta LJ. Use of the artificial beta cell in the assessment of peripheral insulin sensitivity: Effect of Chromium supplementation in diabetes. General Pharmacology. 15:535-539. 1984.
Elwood JC, Nash DT and Streeten DHP. Effect of high chromium brewer's yeast on human serum lipids. J. Am. Coll. Nutr. 1:263, 1982.
Glinsmann WH and Mertz W. Effect of trivalent chromium on glucose tolerance. Metabolism. 15:510-520, 1966.
Kuritzky L. Samraj GP. Quillen DM. Improving management of type 2 diabetes mellitus:. Chromium. Hospital Practice (Office Edition). 35(2):113-6, 2000.
Lee NA and Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care. 17: 1449-1452, 1994.
Lefavi RG, et al. Lipid lowering effect of a dietary chromium(III) nicotinic acid complex in male athletes. Nutr. Res. 13:239249, 1993.
Mertz W. Chromium in human nutrition: A review. J. Nutr. 123:626-633, 1993.
Mossop RT. Effects of chromium III on fasting blood glucose, cholesterol and cholesterol HDL levels in diabetics. Central African Journal of Medicine. 29:80-82, 1983.
Offenbach EG and Pi-Sunyer FX. Chromium in human nutrition. Ann. Rev. Nutr. 8:543-563, 1988.
Potter JF. Levin P. Anderson RA. Freiberg JM. Andres R. Elahi D. Glucose metabolism in glucose-intolerant older people during chromium supplementation. Metabolism: Clinical & Experimental. 34(3):199-204, 1985.
Simonoff M. Chromium deficiency and cardiovascular risk. Cardiovascular Research. 18(10):591-6, 1984.
Simonoff M, et al. Low plasma chromium in patients with coronary artery and heart disease. Biol. Trace Elem. Res. 6:431, 1984.
Urberg M. Benyi J. John R. Hypocholesterolemic effects of nicotinic acid and chromium supplementation. Journal of Family Practice. 27(6):603-6, 1988.
Uusitupa MI. Mykkanen L. Siitonen O. Laakso M. Sarlund H. Kolehmainen P. Rasanen T. Kumpulainen J. Pyorala K. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. British Journal of Nutrition. 68(1):209-16, 1992.
Uusipta MI, et al. Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in non-insulin-dependent diabetics. Am. J. Clin. Nutr. 38:404-410, 1983.
The information provided in any multimedia presentation by Eniva is intended for educational purposes, and has not been evaluated by the Food and Drug Administration. Eniva products are not intended to diagnose, treat, cure or prevent any disease, nor are they meant as a replacement for medical advice or treatment. As always, before beginning any supplementation Program check with your qualified health care provider." All productions are copyrighted by Eniva Nutraceutics and cannot be copied or reused without advance permission.
This site is best viewed with IE7+ or FireFox 2.0+, DSL or high-speed internet,
1024 x 768 screen resolution, Shockwave/Flash plugin also required.